Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell LymphomaSimon Le Gallou, Mikaël Roussel, Gandhi Damaj et al.|Frontiers in Immunology|2021Cited by 18
Safety and efficacy of a dexamethasone-sparing regimen with daratumumab and lenalidomide in patients with frailty and newly diagnosed multiple myeloma (IFM2017-03): a phase 3, open-label, multicentre, randomised, controlled trialSalomon Manier, Thierry Façon, Jérôme Lambert et al.|The Lancet Oncology|2025Cited by 13
Immune‐mediated thrombotic thrombocytopenic purpura prognosis is affected by blood pressureAdrien Joseph, Paul Coppo, Martin Eloit et al.|Research and Practice in Thrombosis and Haemostasis|2022Cited by 7
Nonclassical monocytes are prone to migrate into tumor in diffuse large B-cell lymphomaSimon Le Gallou, Mikaël Roussel, Faustine Lhomme et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 2
A Dexamethasone Sparing-Regimen with Daratumumab and Lenalidomide in Frail Patients with Newly-Diagnosed Multiple Myeloma: The IFM2017-03 Phase 3 TrialSalomon Manier, Thierry Façon, Jérôme Lambert et al.|SSRN Electronic Journal|2025Cited by 1